Category: Health & Medicines > Health Care Supplement
Country/Region: China State/Province: Beijing
Main Products: RCs, Etizolam, 2fdck, 5f Mdmb 2201, Eutylone Etc
Business Type: Manufacturer, Trader
Year Established: 2004
Employees: Above 1000 People
Plant Area: Below 1,000 square meters
Main Markets: South America 9% Africa 11% Eastern Asia 8% Domestic Market 10% North America 9% Eastern Europe 10% Southern Europe 12% Mid East 12% Northern Europe 8% Oceania 11%
Trade Capacity: FOB, CIF, CPT
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Beijing
Annual Revenue: US$1 Million - US$2.5 Million
Total Revenue: Above US$100 Million
Export Revenue: US$2.5 Million - US$5 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: US$1 Million - US$2.5 Million
Export Percentage: 21% - 30%
Payment Modes: USD, CAD, HKD
Lead Time: 26 days
Import/Export Mode: Using an agent